Didanosine

Product NDC: 65862-311
11-digit product format: 658620311
Labeler code: 65862
Product ID: 65862-311_e8187d15-dc5b-4f8f-903c-cf1733d9a135
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Didanosine
Dosage form: CAPSULE, DELAYED RELEASE
Route: ORAL
Labeler: Aurobindo Pharma Limited
Application: ANDA090094
Marketing category: ANDA
Marketing start: 2008-09-24
Marketing end: 0000-00-00
Substance: DIDANOSINE
Active strength: 200 mg/1
Pharmacologic classes: Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2020-12-31
Current FDA listing: Historical FDA.report record

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
65862-311-30	EA - Each	65862-311	79356fb7-251c-416c-924c-c71b22a22171	1	2012-07-24

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
K3GDH6OH08	DIDANOSINE	69655-05-6	DIDANOSINE

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
65862-311-05	65862031105	500 CAPSULE, DELAYED RELEASE in 1 BOTTLE (65862-311-05)		2008-09-24	0000-00-00	No	No	Current
65862-311-10	65862031110	10 BLISTER PACK in 1 CARTON (65862-311-10) > 10 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK	10 blister pack	2008-09-24	0000-00-00	No	No	Current
65862-311-30	65862031130	30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (65862-311-30)		2008-09-24	0000-00-00	No	No	Current